Quercetin-3-O-(2"-galloyl)-a-L-rhamnopyranoside prevents TRAIL-induced apoptosis in human keratinocytes by suppressing the caspase-8- and Bid-pathways and the mitochondrial pathway

Chemico-Biological Interactions

Volumn 204, Issue 3, 2013, Pages 144-152

  Kim, Yun Jeong ^a   Jung, Eun Byul ^a   Seo, Seong Jun ^b   Park, Kwan Hee ^a   Lee, Min Won ^a   Lee, Chung Soo ^a  

^a Chung Ang University   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

Author keywords

Apoptosis related protein activation; Human keratinocytes; QGR; Skin diseases; TRAIL

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN P53; QUERCETIN; QUERCETIN 3 O (2'' GALLOYL) ALPHA RHAMNOPYRANOSIDE; QUERCETIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; SURVIVIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA DETERMINATION; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG ISOLATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KERATINOCYTE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PROTEIN CLEAVAGE; PROTEIN SECRETION; WESTERN BLOTTING;

EID: 84879055329     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2013.05.009     Document Type: Article

References (42)

1. A. Trautmann, M. Akdis, D. Kleemann, F. Altznauer, H.U. Simon, T. Graeva, M. Noll, E.B. Bröcker, K. Blaser, C.A. Akdis, T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis, J. Clin. Invest. 106 (2000) 25-35.
2. F.C. Kimberley, G.R. Screaton, Following a TRAIL: update on a ligand and its five receptors, Cell Res. 14 (2004) 359-372.
3. E. Vassina, M. Leverkus, S. Yousefi, L.R. Braathen, H.U. Simon, D. Simon, Increased expression and a potential anti-Inflammatory role of TRAIL in atopic dermatitis, J. Invest. Dermatol. 125 (2005) 746-752.
4. P. Warnnissorn, A. Nakao, H. Suto, H. Ushio, N. Yamaguchi, H. Yagita, K. Okumura, H. Ogawa, Tumour necrosis factor-related apoptosis-inducing ligand expression in atopic dermatitis, Br. J. Dermatol. 148 (2003) 829-831.
5. S. Pastore, F. Mascia, G. Girolomoni, The contribution of keratinocytes to the pathogenesis of atopic dermatitis, Eur. J. Dermatol. 16 (2006) 125-131.
6. D. Tsuruta, NF-jB links keratinocytes and lymphocytes in the pathogenesis of psoriasis, Recent Pat. Inflammation Allergy Drug Discovery 3 (2009) 40-48.
7. I. Boehm, Apoptosis in physiology and pathologic skin: implications for therapy, Curr. Mol. Med. 6 (2006) 375-394.
8. A. Trautmann, M. Akdis, P. Schmid-Grendelmeier, R. Disch, E.B. Brocker, K. Blaser, C.A. Akdis, Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis, J. Allergy Clin. Immunol. 108 (2001) 839-846.
9. G.S. Wu, TRAIL as a target in anti-cancer therapy, Cancer Lett. 285 (2009) 1-5.
10. Z. Mahmood, Y. Shukla, Death receptors: targets for cancer therapy, Exp. Cell Res. 316 (2010) 887-899.
11. M. Ishibashi, T. Ohtsuki, Studies on search for bioactive natural products targeting TRAIL signaling leading to tumor cell apoptosis, Med. Res. Rev. 28 (2008) 688-714.
12. L. Potenza, C. Calcabrini, R. De Bellis, U. Mancini, L. Cucchiarini, M. Dachà, Effect of quercetin on oxidative nuclear and mitochondrial DNA damage, Biofactors 33 (2008) 33-48.
13. F.T. Vicentini, T. He, Y. Shao, M.J. Fonseca, W.A. Verri Jr, G.J. Fisher, Y. Xu, Quercetin inhibits UV irradiation-induced inflammatory cytokine production in primary human keratinocytes by suppressing NF-jB pathway, J. Dermatol. Sci. 61 (2011) 162-168.
14. S.E. Choi, K.H. Park, B.H. Han, M.S. Jeong, S.J. Seo, D.I. Lee, S.S. Joo, M.W. Lee, Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by phenolic compounds from roots of Rhododendron mucronulatum, Phytother. Res. (2011), http://dx.doi.org/10.1002/ptr.3376.
15. X.Y. Wang, P.Y. He, J. Du, J.Z. Zhang, Quercetin in combating H2O2 induced early cell apoptosis and mitochondrial damage to normal human keratinocytes, Chin. Med. J. (England) 123 (2010) 532-536.
16. K.V. Hirpara, P. Aggarwal, A.J. Mukherjee, N. Joshi, A.C. Burman, Quercetin and its derivatives: synthesis, pharmacological uses with special emphasis on antitumor properties and prodrug with enhanced bio-availability, Anticancer Agents Med. Chem. 9 (2009) 138-161.
17. Y.H. Jung, J. Heo, Y.J. Lee, T.K. Kwon, Y.H. Kim, Quercetin enhances TRAILinduced apoptosis in prostate cancer cells via increased protein stability of death receptor 5, Life Sci. 86 (2010) 351-357.
18. W.J. Lee, Y.R. Chen, T.H. Tseng, Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells, Oncol. Rep. 25 (2011) 583-591.
19. M. Russo, C. Spagnuolo, S. Volpe, A. Mupo, I. Tedesco, G.L. Russo, Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients, Br. J. Cancer 103 (2010) 642-648.
20. V. Kostyuk, A. Potapovich, T. Suhan, C. De Luca, G. Pressi, R. Dal Toso, L. Korkina, Plant polyphenols against UV-C-induced cellular death, Planta Med. 74 (2008) 509-514.
21. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods 65 (1983) 55-63.
22. V. Andrisano, R. Ballardini, P. Hrelia, N. Cameli, A. Tosti, R. Gotti, V. Cavrini, Studies on the photostability and in vitro phototoxicity of labetalol, Eur. J. Pharm. Sci. 12 (2001) 495-504.
23. Y. Dai, M. Liu, W. Tang, Y. Li, J. Lian, T.S. Lawrence, L. Xu, A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-jB, BMC Cancer 9 (2009) 392.
24. H. Wu, G.N. Rao, B. Dai, P. Singh, Autocrine gastrins in colon cancer cells upregulate cytochrome c oxidase Vb and down-regulate efflux of cytochrome c and activation of caspase-8, J. Biol. Chem. 275 (2000) 32491-32498.
25. A. Berthier, S. Lemaire-Ewing, C. Prunet, S. Monier, A. Athias, G. Bessede, J.P. Pais de Barros, A. Laubriet, P. Gambert, G. Lizard, D. Néel, Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis, Cell Death Differ. 11 (2004) 897-905.
26. W. Fu, H. Luo, S. Parthasarathy, M.P. Mattson, Catecholamines potentiate amyloid -peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis, Neurobiol. Dis. 5 (1998) 229-243.
27. M. MacFarlane, TRAIL-induced signaling and apoptosis, Toxicol. Lett. 139 (2003) 89-97.
28. W. Hu, J.J. Kavanagh, Anticancer therapy targeting the apoptotic pathway, Lancet Oncol. 4 (2003) 721-729.
29. Z. Jin, W.S. El-Deiry, Overview of cell death signaling pathways, Cancer Biol. Ther. 4 (2005) 139-163.
30. P. Bernardi, A. Krauskopf, E. Basso, V. Petronilli, E. Blachly-Dyson, F. Di Lisa, M.A. Forte, The mitochondrial permeability transition from in vitro artifact to disease target, FEBS J. 273 (2006) 2077-2099.
31. S. Javadov, M. Karmazyn, Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection, Cell. Physiol. Biochem. 20 (2007) 1-22.
32. V. Borutaite, Mitochondria as decision-makers in cell death, Environ. Mol. Mutagen. 51 (2010) 406-416.
33. V. Shoshan-Barmatz, D. Mizrachi, VDAC1: from structure to cancer therapy, Front. Oncol. 2 (2012) 164.
34. A.D. Chacko, F. Liberante, I. Paul, D.B. Longley, D.A. Fennell, Voltage dependent anion channel-1 regulates death receptor mediated apoptosis by enabling cleavage of caspase-8, BMC Cancer 10 (2010) 380.
35. J.E. Chipuk, D.R. Green, Dissecting p53-dependent apoptosis, Cell Death Differ. 13 (2006) 994-1002.
36. K.G. Wiman, Strategies for therapeutic targeting of the p53 pathway in cancer, Cell Death Differ. 13 (2006) 921-926.
37. F. Chen, W. Wang, W.S. El-Deiry, Current strategies to target p53 in cancer, Biochem. Pharmacol. 80 (2010) 724-730.
38. B. Mignotte, J.L. Vayssière, Mitochondria and apoptosis, Eur. J. Biochem. 252 (1998) 1-15.
39. M. Shakibaei, G. Schulz-Tanzil, Y. Takeda, B.B. Aggarwal, Redox regulation of apoptosis by members of the TNF superfamily, Antioxid. Redox Signaling 7 (2005) 482-496.
40. B.H. Kim, S.M. Cho, Y.S. Chang, S.B. Han, Y. Kim, Effect of quercitrin gallate on zymosan A-induced peroxynitrite production in macrophages, Arch. Pharm. Res. 30 (2007) 733-738.
41. H.Y. Jo, Y. Kim, S.Y. Nam, B.J. Lee, Y.B. Kim, Y.W. Yun, B. Ahn, The inhibitory effect of quercitrin gallate on iNOS expression induced by lipopolysaccharide in Balb/c mice, J. Vet. Sci. 9 (2008) 267-272.
42. M. Ramalingam, S.J. Kim, Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases, J. Neural. Transm. 119 (2012) 891-910.